help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Natkunam, Y.
Right arrow Articles by van de Rijn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Natkunam, Y.
Right arrow Articles by van de Rijn, M.
(American Journal of Pathology. 2000;156:21-27.)
© 2000 American Society for Investigative Pathology

Short Communications

Immunoblot Analysis of CD34 Expression in Histologically Diverse Neoplasms

Yasodha Natkunam*, Robert V. Rouse*, Shirley Zhu*, Cyril Fisher{dagger} and Matthijs van de Rijn*

From the Department of Pathology,*
Stanford University Medical Center, Stanford, California; and The Royal Marsden National Health Service Trust,{dagger}
London, United Kingdom

CD34 is a heavily glycosylated transmembrane protein of ~110 kd whose function is essentially uncharacterized. First identified in a myeloid leukemia cell line, immunohistological reactivity with anti-CD34 antibodies is also encountered in a histologically diverse subset of nonhematolymphoid neoplasms including angiosarcoma, solitary fibrous tumors, epithelioid sarcomas, spindle cell lipomas, dermatofibrosarcoma protuberans, and myofibroblastomas. Immunohistological reactivity for CD34 in hematopoietic stem cells and endothelial cells has been shown to correspond to the expression of the CD34 protein. With the exception of gastrointestinal stromal tumors, CD34 protein expression has not been investigated in other CD34 immunohistologically reactive nonhematolymphoid neoplasms. We undertook this study to examine whether the observed reactivity for anti-CD34 antibodies in apparently unrelated tumors is due to the expression of the same protein or whether shared epitopes elaborated by other proteins could account for this reactivity. Immunoblot analyses with anti-CD34 antibodies of six different CD34 immunohistologically reactive lesions show the same ~110-kd molecular weight protein. In addition, two cases of dermatofibrosarcoma protuberans show double bands at ~110 kd. Laser-capture microdissection of CD34 immunohistologically reactive epithelioid sarcoma and nonreactive epidermal cells illustrates that this reactivity is specific to tumor cells. These results show that the observed immunohistological reactivity with anti-CD34 antibodies is due to the expression of the CD34 protein and not to shared epitopes on unrelated proteins.




This article has been cited by other articles:


Home page
 ChestHome page
M. Takahama, K. Kushibe, T. Kawaguchi, M. Kimura, and S. Taniguchi
Video-Assisted Thoracoscopic Surgery Is a Promising Treatment for Solitary Fibrous Tumor of the Pleura
Chest, March 1, 2004; 125(3): 1144 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. C. Linn, R. B. West, J. R. Pollack, S. Zhu, T. Hernandez-Boussard, T. O. Nielsen, B. P. Rubin, R. Patel, J. R. Goldblum, D. Siegmund, et al.
Gene Expression Patterns and Gene Copy Number Changes in Dermatofibrosarcoma Protuberans
Am. J. Pathol., December 1, 2003; 163(6): 2383 - 2395.
[Abstract] [Full Text]

Home page
 J. Clin. Pathol.Home page
F. Fend and M. Raffeld
Laser capture microdissection in pathology
J. Clin. Pathol., September 1, 2000; 53(9): 666 - 672.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.